Market narrative
Move between stock news, official company releases, crypto, and FX without losing the path back to ticker research.
Service Corporation International NYSE: SCI reported second-quarter 2026 earnings per share of $0.90, up from $0.88 a year earlier, as growth in cemetery revenue and trust fund income more than offset pressure from lower funeral volumes and deferred cemetery revenue.
Stocks
Companies that have reported in the Q2 cycle are offering encouraging reads on order trends, margin resilience, and full-year demand. This fundamental health is filtering directly into analyst models, driving a steady stream of upward revisions for Q3 and beyond.
Jacob Tsimerman won the biggest prize in math. Now he's working on the most important problem of his career.
Bets on consumer chatbots and flashy side projects overshadowed AI coding opportunity, which rival Anthropic used to capture the lead.
[url="]Robbins LLP[/url] informs investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acqui
Pacific Gas and Electric Company Announces Results of Cash Tender Offers PR Newswire OAKLAND, Calif., July 31, 202
Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Wise Group plc (NA
[url="]Kahn Swick and Foti[/url], LLC (âKSFâ) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in [url="]Capric
Lloyds Banking Group plc (LYG) Q2 2026 Earnings Call Transcript
Taylor Wimpey plc (TWODY) Q2 2026 Earnings Call Transcript
SAN DIEGO--(BUSINESS WIRE)---- $CAPR #Biologics--Robbins LLP informs investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Capricor Therapeutics, Inc. (NASDAQ: CAPR) securities between December 17, 2025 and July 26, 2026 (the "Class Period").The lawsuit alleges that Capricor Therapeutics misled investors regarding the path to FDA approval for its lead product candidate Deramiocel, a cell therapy to address cardiac and skeletal muscle compli.
VANCOUVER, British Columbia, July 31, 2026 (GLOBE NEWSWIRE) -- Anfield Energy Inc. ("Anfield" or the "Company") (TSX. V: AEC; NASDAQ: AEC; FRANKFURT: 0AD) has closed its previously announced underwritten public offering (the "Offering") of 1,715,000 common shares (the "Common Shares"), which includes the full exercise of the underwriters' option to purchase an additional 233,695 Common Shares, at a price of US$4.
VANCOUVER, British Columbia, July 31, 2026 (GLOBE NEWSWIRE) -- Anfield Energy Inc. (“Anfield” or the “Company”) (TSX.V: AEC; NASDAQ: AEC; FRANKFURT: 0AD) has closed its previously announced underwritten public offering (the “Offering”) of 1,715,000 common shares (the “Common Shares”), which includes the full exercise of the underwriters' option to purchase an additional 233,695 Common Shares, at a price of US$4.00 per Common Share for aggregate gross proceeds to the Company of US$6.9 million.
Your savings account feels harmless enough until you do the actual math on what sitting still costs over a decade. The number might make you angry enough to open a new tab.
On July 24, 2026, Murray Stahl (Trades, Portfolio), through Horizon Kinetics, increased the firm's position in RENN Fund Inc (NYSE: RCG) by purchasing 756 additi
/PRNewswire/ -- Simparo Inc. (DBA Simparo Surgical), an Alabama medical device company backed by an investment from Innovate Alabama, and supported by Hatch
NEW YORK, July 31, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Class A common stock of GPGI, Inc. f/k/a CompoSecure, Inc. (NYSE: GPGI, CMPO) between November 3, 2025 and May 6, 2026, inclusive (the “Class Period”), of the important September 14, 2026 lead plaintiff deadline.
NEW YORK, July 31, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Class A common stock of GPGI, Inc. f/k/a CompoSecure, Inc. (NYSE: GPGI, CMPO) between November 3, 2025 and May 6, 2026, inclusive (the "Class Period"), of the important September 14, 2026 lead plaintiff deadline.
SAN DIEGO, July 31, 2026 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Park Ha Biological Technology Co. , Ltd. (NASDAQ: BYAH) securities between December 27, 2024 and July 8, 2025 (the "Class Period").
SAN DIEGO, July 31, 2026 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) securities between December 27, 2024 and July 8, 2025 (the "Class Period").
